Gender/age,y | M/63 | F/42 |
Occupation | farmer | farmer |
Onset to admission, d | 8 | 7 |
Tick bite history | + | + |
Fever | + | + |
Gastrointestinal symptomsa | + | + |
Lymphadenopathy | + | + |
Rash | + | + |
Fatigue | + | _ |
hemorrhageb | _ | + |
Apathy | _ | + |
WBC (3.5–9.5a10~ 9/L) | 24.46 | 2.58 |
RBC(M: 4.3–5.8a10~ 12/L, F: 3.8–5.1a10~ 12/L) | 3.86 | 4.03 |
PLT(125–350a10~ 9/L) | 75 | 25 |
PT(11.0–13.7 s) | 16.9 | 17.5 |
Fg(2.00–4.00 g/L) | 2.9 | 1.82 |
APTT(31.5–43.5 s) | 68.3 | 90.0 |
Proteinuria | 1+ | microscale |
AMY(28–100 U/L) | 30 | 230 |
LPS(13–60 U/L) | 27 | 194 |
ALT(13–69 U/L) | 37 | 727 |
AST(15–46 U/L) | 28 | 2940 |
ALP(38–126 U/L) | 244 | 120 |
LDH(135–225 U/L) | 794(313–618 U/L) | 2690 |
CK(39–308 U/L) | 21 | 1086 |
Immunofixation electrophoresis | polyclonal IgG | polyclonal IgG |
IgA(0.82–4.53 g/L) | 2.64 | 2.43 |
IgG(7.51–15.6 g/L) | 17.2 | 28.5 |
IgM(0.46–3.04 g/L) | 28.1 | 0.76 |
Antibody IgM, RNA of SFTSV | + | + |
Bone marrow cytology | Plasma cells accounting for 29.2%: naïve (6.8%) and mature (22.4%) ones. | (2014-7-18) Plasma cells accounting for 50.4%: naïve (39.6%) and mature (10.8%); (2014-7-31) normal mature plasma cells accounting for 2.2%, no naive plasma cells. |
Flow cytometric immunophenotyping(FCI) | Plasma cells of normal phenotype accounting for 20%, mainly expressing CD38, CD 138, CD19; partly expressing CD 200, cKappa, and cLambda, not expressed CD20, Kappa, Lambda, CD25, CD35, CD22, FMC7, CD103, CD10, CD5, IgM, CD23, CD117, and CD56. | (2014-7-18) Plasma cells of abnormal phenotype accounting for 44.7%, mainly expressing CD38, CD 138, CD19, and cLambda; not expressing CD7, CD117, CD33, CD10, CD34, CD28, CD56, CD25, CD11c, CD5, FMC7, CD22, TdT, CD200, CD20, Kappa, Lambda, and cKappa. (2014-7-31) Plasma cells of normal phenotype accounting for 1.1%, mainly expressing CD38, CD138, CD19, partly expressing cKappa and cLambda. |
outcome | Recoverd | Recoverdc |